Today: 30 January 2026
Subscribe
Browse Category

NASDAQ:CATX News 30 January 2026

Perspective Therapeutics stock (CATX) steadies before the open after 66% jump — what investors watch next

Perspective Therapeutics stock (CATX) steadies before the open after 66% jump — what investors watch next

New York, January 30, 2026, 05:34 EST — Premarket Shares of Perspective Therapeutics Inc dipped 0.8% to $4.22 in early premarket trade on Friday, following a strong 66.4% gain to $4.26 the day before, according to MarketBeat data. (MarketBeat) This matters since Perspective is a small-cap cancer drug developer, and its stock can swing sharply when investors pile in. That…
30 January 2026
·····

Stock Market Today

  • Chevron Q4 Earnings Beat Estimates Amid Revenue Miss
    January 30, 2026, 9:02 AM EST. Chevron (CVX) reported Q4 earnings of $1.52 per share, beating the Zacks consensus estimate of $1.44. This marks a 5.24% earnings surprise but represents a decline from $2.06 per share a year ago. Revenue missed expectations, falling 8.87% short at $46.87 billion versus a year-ago $52.23 billion. Chevron has outpaced earnings estimates in the last four quarters but has consistently missed revenue targets. Shares have gained 12.3% year-to-date, outperforming the S&P 500's 1.8% rise. Despite strong earnings beats, Chevron holds a Zacks Rank #4 (Sell) due to recent unfavorable earnings estimate revisions, suggesting potential underperformance ahead. The oil and gas industry segment ranks near the bottom 13% in Zacks' rankings, adding to cautious outlook for investors.
Go toTop